UPN | Reason for DI therapy | No. of DI cycles administered | Study progress | Best response | Outcome | PFS (months) | Follow-up period (months) |
---|---|---|---|---|---|---|---|
1 | SPD | 14 | Completed | CR | DOD | 12.4 | 17.1 |
2 | 2nd relapse | 3 | Stopped | PD | DOD | 2.2 | 24.6 |
3 | PPD | 1 | Stopped | PD | DOD | 0.5 | 1.5 |
4 | PPD | 2 | Stopped | PD | DOD | 1.4 | 1.9 |
5 | PPD | 1 | Stopped | PD | DOD | 0.5 | 1 |
6 | SPD | 15 | Completed | PR* | AWD | 16.9 | 41.3 |
7 | PPD | 2 | Stopped | PD | DOD | 1.4 | 6.2 |
8 | PPD | 4 | Stopped | SD† | DOD | 3.1 | 10.1 |
9 | 3rd relapse | 9 | Ongoing | PR* | NED | 6.4 | 6.4 |